University of Tennessee Health Science Center, Memphis, Tennessee.
Section of Allergy and Clinical Immunology, Saint Louis University School of Medicine, St Louis, Missouri.
Ann Allergy Asthma Immunol. 2014 Apr;112(4):322-8.e1. doi: 10.1016/j.anai.2014.02.006.
Allergic rhinoconjunctivitis (ARC) is managed by a number of health care professional specialties, whose practice styles may vary.
To survey patients and health care professionals about the diagnosis and treatment of ARC.
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys were telephone surveys of randomly selected patients and health care professionals in the United States in 2012. Participants were 2,765 people ever diagnosed as having nasal and/or ocular allergies and 500 practitioners in 7 specialties who were treating ARC.
Adult respondents to the patient survey reported that their allergies had been diagnosed most often by physicians in family practice (46%) rather than by allergists/immunologists (17%) or otolaryngologists (11%). Children's allergies had been diagnosed most often by pediatricians (41%) and family practitioners (22%). Most respondents with conditions diagnosed by an allergist/immunologist (94.9%) or otolaryngologist (62.7%) had been given an allergy test, but the test was not given to most patients with conditions diagnosed by family practitioners (61.3%) or pediatricians (64.9%). Most patients (75.8%) were treating their allergies with over-the-counter medications, and 53.5% were taking prescription medications. Allergen immunotherapy was being used by 33% (adult) or 28% (child) patients of allergist/immunologists, 25% (adult) or 24% (child) patients of otolaryngologists, and 8% and 10% of patients of family practitioners and pediatricians, respectively.
Most patients took nonprescription medications for their allergy symptoms or were treated by general practitioners, who did not use allergy testing when diagnosing ARC. Most patients seen by allergist/immunologists and otolaryngologists were evaluated with allergy tests, and most allergen immunotherapy was provided by allergy specialists.
变应性鼻结膜炎(ARC)由许多医疗保健专业人员管理,其治疗风格可能有所不同。
调查患者和医疗保健专业人员对 ARC 的诊断和治疗情况。
Allergies, Immunotherapy, and RhinoconjunctivitiS(AIRS)调查是 2012 年对美国随机选择的患者和医疗保健专业人员进行的电话调查。参与者包括 2765 名曾被诊断为患有鼻和/或眼部过敏的患者,以及 500 名治疗 ARC 的 7 个专业的从业者。
接受患者调查的成年受访者报告说,他们的过敏症最常由家庭医生(46%)而不是过敏症/免疫学家(17%)或耳鼻喉科医生(11%)诊断。儿童的过敏症最常由儿科医生(41%)和家庭医生(22%)诊断。大多数由过敏症/免疫学家(94.9%)或耳鼻喉科医生(62.7%)诊断的患者接受了过敏测试,但大多数由家庭医生(61.3%)或儿科医生(64.9%)诊断的患者未接受该测试。大多数患者(75.8%)正在使用非处方药物治疗过敏症,53.5%正在服用处方药。过敏免疫疗法正在被 33%(成人)或 28%(儿童)的过敏症/免疫学家患者、25%(成人)或 24%(儿童)的耳鼻喉科医生患者、8%和 10%的家庭医生和儿科医生患者使用。
大多数患者因过敏症状服用非处方药物或由全科医生治疗,全科医生在诊断 ARC 时不使用过敏测试。大多数接受过敏症/免疫学家和耳鼻喉科医生治疗的患者都接受了过敏测试,大多数过敏免疫疗法都由过敏症专家提供。